Novo Nordisk stock will ride a wave of demand for Ozempic pills in 2026.

There might be massive upside ahead for these drugmakers.

Over the last 10 years, West Pharmaceutical Services stock has attracted buying interest at this level 7 times and has ...

Both could reward patient investors down the line.

From pharma to media, eight Indian stocks earn ‘Buy’ calls from multiple brokerages, with upside potential touching 90%.

Milestone Pharmaceuticals (MIST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near ...

Investing.com -- Citi has initiated coverage of the “Big 6” European pharmaceutical groups with a positive sector view, rating AstraZeneca (LON: AZN ), Novartis AG (SIX: NOVN) and Roche (SIX: ROG) at ...

Top pharma stocks by Quant Ratings: see Strong Buy/Buy picks across PJP/XPH/PPH—plus why Moderna surged on new cancer-trial ...

Bristol Myers Squibb and Microsoft 's new partnership aimed at accelerating early detection of lung cancer marks the latest ...

Citi launched broad coverage of major European pharmaceutical companies with a mixed outlook, issuing Buy ratings on AstraZeneca and Novartis while taking a more cautious stance on GSK, Novo Nordisk ...

Under the plan, the shares, worth Tk43 crore with each costing Tk215.20, will be acquired from both the public market and through block transactions on the DSE within the next 30 working days.

Novartis (NVS) is trading at new all-time highs on Monday. ・Shares are up nearly 50% over the past 52 weeks. ・NVS maintains a ...